eFFECTOR Therapeutics, Inc. (EFTR) — Analyst outlook / Analyst consensus target is. Based on 6 analyst ratings, the consensus is bullish — 6 Buy.
The consensus price target is $5.50 (low: $1.00, high: $10.00), representing an upside of 2749900% from the current price $0.00.
EFTR Stock — 12-Month Price Forecast
$5.50
▲ +2,749,900.00% Upside
Average Price Target
Based on 6 Wall Street analysts offering 12-month price targets for eFFECTOR Therapeutics, Inc., the average price target is $5.50, with a high forecast of $10.00, and a low forecast of $1.00.
The average price target represents a +2,749,900.00% change from the last price of $0.00.
Highest Price Target
$10.00
Average Price Target
$5.50
Lowest Price Target
$1.00
EFTR Analyst Ratings
Buy
Based on 6 analysts giving stock ratings to eFFECTOR Therapeutics, Inc. in the past 3 months
